Tiny study on gut hormones and bone health in disabled kids ends early
NCT ID NCT07254988
First seen Jan 04, 2026 · Last updated May 18, 2026 · Updated 16 times
Summary
This study looked at whether two gut hormones (GIP and GLP-2) could reduce bone breakdown in children with spinal muscular atrophy, cerebral palsy, or Duchenne muscular dystrophy who use wheelchairs. Only 3 children were enrolled before the study was stopped early. The goal was to measure changes in bone resorption markers, but no conclusions can be drawn due to the small size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY (CP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rigshospitalet
Copenhagen, Denmark
Conditions
Explore the condition pages connected to this study.